List view / Grid view

Stephan Kutzer

Filter the results

 

news

Lonza and OncoMed Pharmaceuticals sign a process development and manufacturing collaboration and multi-product GS license agreement

Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals,…

23 October 2012 | By

Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and manufacture of OncoMed’s pipeline of anti-cancer stem cell therapeutics.